Grants and Contributions:
Title:
Optimizing AI portability and scalability for personalized therapeutic music intervention in dementia care
Agreement Number:
1033045
Agreement Value:
$300,000.00
Agreement Date:
Jul 2, 2025 - Aug 15, 2026
Description:
This project aims to enhance LUCID’s AI-driven music therapeutic system for dementia care by integrating and developing scalable and portable AI modules. These advancements will enable personalized music interventions to scale to a larger population in the United States and in the Pacific region, with an initial focus on Japan and South Korea.
Organization:
National Research Council Canada
Expected Results:
The expected results and outcomes of NRC Industrial Research Assistance Program is focused on growing small and medium-sized enterprises (SMEs) through innovation and wealth creation for Canada.
Location:
Toronto, Ontario, CA M4T 1P7
Reference Number:
172-2025-2026-Q2-1033045
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
784783318
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 31 days.
Amendment Date
May 25, 2026
Recipient's Operating Name:
Lucid Therapeutics
Recipient's Legal Name:
Lucid, inc.
Federal Riding Name:
University--Rosedale
Federal Riding Number:
35110
Program:
Industrial Research Assistance Program
Program Purpose:
The purpose of Industrial Research Assistance Program Contributions to Firms is to provide support that assists small and medium-sized enterprises (SMEs) to advance their innovation knowledge and ability to innovate, grow through innovation and stimulate wealth creation for Canada.
Coverage:
Industrial Research Assistance Program projects stimulate wealth creation for Canada through technological innovation and strengthen Canadian innovation ecosystem by creating new industrial capacity.
NAICS Code:
51121
Amendments: